Australia markets closed

Entera Bio Ltd. (ENTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.0700-0.1500 (-6.76%)
At close: 04:00PM EDT
2.0700 0.00 (0.00%)
Pre-market: 08:00AM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
285
0
134
571
365
Cost of revenue
229
0
101
373
300
Gross profit
56
0
33
198
65
Operating expenses
Research development
7,146
4,510
5,848
6,771
6,382
Selling general and administrative
6,994
4,430
7,253
5,690
4,851
Total operating expenses
14,093
8,891
13,050
12,415
11,233
Operating income or loss
-14,037
-8,891
-13,017
-12,217
-11,168
Interest expense
-
-
-
29
28
Total other income/expenses net
-
-
-
-
1,237
Income before tax
-14,164
-8,860
-12,934
-12,246
-11,196
Income tax expense
-286
29
137
-59
20
Income from continuing operations
-13,878
-8,889
-13,071
-12,187
-11,216
Net income
-13,878
-8,889
-13,071
-12,187
-11,216
Net income available to common shareholders
-13,878
-8,889
-13,071
-12,187
-11,216
Basic EPS
-0.34
-0.31
-0.45
-0.47
-0.67
Diluted EPS
-0.34
-0.31
-0.45
-0.47
-0.67
Basic average shares
28,812
29,008
28,808
26,134
18,417
Diluted average shares
28,812
29,008
28,808
26,134
18,417